EUVIMEDFaigh amach EUVIMED
Open access

The diagnostic likelihood ratio function and modified test for trend: Identifying, evaluating, and validating nontraditional biomarkers in case‐control studies

Hanna Lindner iD, Phyllis A Gimotty, Warren B Bilker iD

Statistics in Medicine · 2023

DOI: 10.1002/sim.9912 ↗

At a glance

Journal article in Statistics in Medicine, 2023. Written by Hanna Lindner and 2 co-authors. Institution: Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Biomarkers, Clinical Decision-Making. Cited 3 times so far (Crossref); 40 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS, National Institute of Mental Health.

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

The ROC curve and its associated summary statistic, the AUC, are used to identify informative diagnostic biomarkers under the assumption that risk of disease is a monotone function of the biomarker. We refer to biomarkers that meet this assumption as traditional, and those that do not as nontraditional. Nontraditional biomarkers most often arise when both low and high biomarker values are associated with an outcome of interest, such as blood pressure with medical complications or leukocyte count with ICU prognosis. Since nontraditional biomarkers do not meet the assumptions for ROC‐based analyses, we propose using the discrete diagnostic likelihood ratio (DLR) function to evaluate a wider class of informative biomarkers. We obtain the DLR function using the multinomial logistic regression (MLR) model to improve upon existing estimation techniques, and implement a likelihood ratio test to identify candidate informative traditional and nontraditional biomarkers. We propose a modification of the Cochran‐Armitage test for trend that separates biomarkers deemed informative into traditional and nontraditional categories. The statistical properties of the likelihood ratio test and modified test for trend are explored under simulation. Together, these methods achieve the identification, evaluation, and validation of biomarkers from early discovery research. Finally, we show that incorporating covariates into the MLR model results in a covariate‐adjusted DLR function that is useful for integrating multiple sources of information in clinical decision making. The methods are applied to gene expression data from subjects with high grade serous ovarian cancer, where stage, early stage vs late stage, is the outcome of interest.

Subjects

MeSH terms (MEDLINE)

BiomarkersClinical Decision-MakingHumansBlood PressureCase-Control StudiesLikelihood FunctionsROC Curve

Author keywords

ROC curveclinical decision makingdiagnostic biomarkersdiagnostic likelihood ratiomultinomial regressiontest for trend

Substances

Biomarkers

Authors and institutions

  • Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID profiles: Hanna Lindner, Warren B Bilker

Funding

  • NIMH NIH HHS
  • National Institute of Mental Health

Cite

APA

Lindner, H., Gimotty, P. A., & Bilker, W. B. (2023). The diagnostic likelihood ratio function and modified test for trend: Identifying, evaluating, and validating nontraditional biomarkers in case‐control studies. Statistics in Medicine. https://doi.org/10.1002/sim.9912

Vancouver

Lindner H, Gimotty PA, Bilker WB. The diagnostic likelihood ratio function and modified test for trend: Identifying, evaluating, and validating nontraditional biomarkers in case‐control studies. Statistics in Medicine. 2023. doi:10.1002/sim.9912

BibTeX
@article{Lindner2023,
  author = {Lindner, Hanna and Gimotty, Phyllis A and Bilker, Warren B},
  title = {The diagnostic likelihood ratio function and modified test for trend: Identifying, evaluating, and validating nontraditional biomarkers in case‐control studies},
  journal = {Statistics in Medicine},
  year = {2023},
  doi = {10.1002/sim.9912}
}
Start for free →